Tag:
myelofibrosis
Latest Headlines
Latest Headlines
New chief takes helm at Promedior and steers a course for Boston
Just a couple of months after Promedior lined up its $21.5 million D round for fibrosis drug work, a new CEO has stepped up to the helm with plans to abandon Philadelphia and head for the bustling biotech hub in Boston.
European committee backs AZ, BMS and Novartis drugs for approval
Several drug companies received nods of support for getting their prized drugs approved for the European market.
UPDATED: Cell Therapeutics lands myelofibrosis drug with $30M upfront
In addition to the $30 million upfront for the Singapore-based biotech, CEO Jim Bianco committed the company to an unspecified set of milestones for the treatment.
YM gets boost after posting promising anemia data on myelofibrosis drug
Shares of YM Biosciences ( $YMI ) got a bump this morning after several analysts gave the developer a pat on the back for the updated midstage results released for its myelofibrosis drug CYT387, a
